Cleared Traditional

K182397 - Diamondback 360 Peripheral Orbital Atherectomy System Exchangeable Series (FDA 510(k) Clearance)

Dec 2018
Decision
100d
Days
Class 2
Risk

K182397 is an FDA 510(k) clearance for the Diamondback 360 Peripheral Orbital Atherectomy System Exchangeable Series. This device is classified as a Catheter, Peripheral, Atherectomy (Class II - Special Controls, product code MCW).

Submitted by Cardiovascular Systems, Inc. (St.Paul, US). The FDA issued a Cleared decision on December 13, 2018, 100 days after receiving the submission on September 4, 2018.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.4875.

Submission Details

510(k) Number K182397 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 04, 2018
Decision Date December 13, 2018
Days to Decision 100 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code MCW — Catheter, Peripheral, Atherectomy
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.4875

Similar Devices — MCW Catheter, Peripheral, Atherectomy

All 8
Rotarex Atherectomy System
K242757 · Bard Peripheral Vascular, Inc. · Jan 2025
Pantheris LV Atherectomy Catheter
K230005 · Avinger, Inc. · Jun 2023
ROTAPRO Rotational Atherectomy System
K220962 · Boston Scientific Corporation · Sep 2022
DIAMONDBACK 360 Peripheral Orbital Atherectomy System, DIAMONDBACK 360 Peripheral Orbital Atherectomy System, Exchangeable Series, Stealth 360 Peripheral Orbital Atherectomy System
K220109 · Cardiovascular Systems, Inc. · Mar 2022
Pantheris System
K212047 · Avinger, Inc. · Nov 2021
Diamonback 360 Peripheral Orbital Atherectomy System, Diamondback 360 Stealth Orbital Atherectomy system
K210586 · Cardiovascular Systems, Inc. · Sep 2021